Previous studies have found that MSAs (such as anti-TIF1-γ and anti-HMGCR) associated with dysphagia in IIM patients are often accompanied by a lower risk of ILD (46, 47). The gene discussed is TRIM33; the disease is acquired idiopathic inflammatory myopathy.